1915

Opening of the James Buchanan Brady Urological Institute at Johns Hopkins (Young, 224ff.; Lesch III, 20-21), with development of 7-yr residency training program (Young, 241). At the Brady Institute, Young and colleagues developed mercurochrome as a local antiseptic of the genitourinary tract and began administering it intravenously for systemic infection in 1922. He was still using it in 1942, in the face of accumulated evidence against its effectiveness: “Led on by his enthusiasm, Young established an early commanding lead over his evidence, and never lost it” (Lesch III, 20-25, quote at 25).